Hillary Lum
Concepts (344)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Advance Care Planning | 40 | 2023 | 191 | 15.910 |
Why?
| Palliative Care | 16 | 2023 | 629 | 3.630 |
Why?
| Patient Portals | 5 | 2020 | 31 | 2.390 |
Why?
| Patient Participation | 5 | 2020 | 369 | 2.160 |
Why?
| Terminal Care | 6 | 2023 | 187 | 2.070 |
Why?
| Hospice Care | 4 | 2022 | 174 | 1.880 |
Why?
| Physicians | 8 | 2023 | 794 | 1.880 |
Why?
| Dementia | 4 | 2023 | 208 | 1.780 |
Why?
| Primary Health Care | 11 | 2023 | 1560 | 1.770 |
Why?
| Suicide, Assisted | 5 | 2023 | 20 | 1.740 |
Why?
| Advance Directives | 8 | 2021 | 62 | 1.600 |
Why?
| Aged | 47 | 2023 | 19657 | 1.590 |
Why?
| Parkinson Disease | 3 | 2020 | 334 | 1.580 |
Why?
| Electronic Health Records | 6 | 2020 | 829 | 1.530 |
Why?
| Communication | 12 | 2022 | 761 | 1.510 |
Why?
| Physician-Patient Relations | 7 | 2019 | 490 | 1.430 |
Why?
| Documentation | 4 | 2020 | 175 | 1.430 |
Why?
| Caregivers | 9 | 2023 | 709 | 1.420 |
Why?
| Pandemics | 7 | 2022 | 1355 | 1.380 |
Why?
| Skilled Nursing Facilities | 5 | 2022 | 122 | 1.370 |
Why?
| Volunteers | 2 | 2019 | 30 | 1.340 |
Why?
| Hospices | 2 | 2022 | 79 | 1.280 |
Why?
| Quality Improvement | 6 | 2023 | 963 | 1.260 |
Why?
| Cognitive Dysfunction | 2 | 2022 | 301 | 1.220 |
Why?
| Surveys and Questionnaires | 18 | 2023 | 4708 | 1.180 |
Why?
| Heart Failure | 6 | 2019 | 1969 | 1.160 |
Why?
| Humans | 97 | 2023 | 118974 | 1.160 |
Why?
| Subacute Care | 4 | 2021 | 74 | 1.090 |
Why?
| Aged, 80 and over | 17 | 2021 | 6561 | 0.990 |
Why?
| Medical Marijuana | 3 | 2020 | 102 | 0.930 |
Why?
| Hospice and Palliative Care Nursing | 2 | 2023 | 67 | 0.920 |
Why?
| Home Care Services | 4 | 2023 | 217 | 0.910 |
Why?
| Life Support Care | 2 | 2020 | 27 | 0.900 |
Why?
| Group Processes | 2 | 2020 | 56 | 0.880 |
Why?
| Health Services for the Aged | 2 | 2020 | 71 | 0.860 |
Why?
| Health Knowledge, Attitudes, Practice | 5 | 2020 | 1185 | 0.860 |
Why?
| Qualitative Research | 10 | 2023 | 953 | 0.840 |
Why?
| Patient Care Team | 3 | 2021 | 521 | 0.820 |
Why?
| Practice Patterns, Physicians' | 3 | 2019 | 1200 | 0.800 |
Why?
| Huntington Disease | 1 | 2021 | 41 | 0.790 |
Why?
| Living Wills | 1 | 2020 | 8 | 0.780 |
Why?
| Housing | 1 | 2022 | 123 | 0.770 |
Why?
| Music Therapy | 1 | 2020 | 21 | 0.760 |
Why?
| Patient-Centered Care | 3 | 2021 | 497 | 0.750 |
Why?
| Music | 1 | 2020 | 36 | 0.740 |
Why?
| Male | 40 | 2022 | 57801 | 0.740 |
Why?
| Virtual Reality | 1 | 2020 | 38 | 0.740 |
Why?
| Female | 45 | 2022 | 61565 | 0.730 |
Why?
| Neurodegenerative Diseases | 1 | 2021 | 99 | 0.710 |
Why?
| Inservice Training | 2 | 2017 | 106 | 0.710 |
Why?
| Internship and Residency | 2 | 2021 | 1001 | 0.700 |
Why?
| Activities of Daily Living | 1 | 2022 | 354 | 0.680 |
Why?
| Ambulatory Care Facilities | 2 | 2019 | 218 | 0.680 |
Why?
| Pharmacists | 1 | 2021 | 238 | 0.680 |
Why?
| Sports | 1 | 2021 | 194 | 0.670 |
Why?
| Antibodies, Monoclonal | 8 | 2021 | 1284 | 0.670 |
Why?
| CD40 Antigens | 4 | 2006 | 80 | 0.660 |
Why?
| Independent Living | 2 | 2018 | 86 | 0.650 |
Why?
| Stakeholder Participation | 1 | 2019 | 69 | 0.650 |
Why?
| Hospitalization | 4 | 2021 | 1785 | 0.640 |
Why?
| Attitude of Health Personnel | 5 | 2022 | 992 | 0.620 |
Why?
| Betacoronavirus | 1 | 2020 | 254 | 0.600 |
Why?
| Alzheimer Disease | 1 | 2023 | 513 | 0.590 |
Why?
| Outpatients | 1 | 2020 | 325 | 0.590 |
Why?
| Perception | 2 | 2020 | 314 | 0.580 |
Why?
| Clinical Protocols | 1 | 2018 | 238 | 0.580 |
Why?
| Medicare | 3 | 2021 | 663 | 0.580 |
Why?
| Social Media | 1 | 2019 | 133 | 0.570 |
Why?
| Physicians, Primary Care | 1 | 2019 | 222 | 0.570 |
Why?
| Geriatric Assessment | 1 | 2018 | 185 | 0.570 |
Why?
| Nurse Practitioners | 1 | 2018 | 107 | 0.570 |
Why?
| Marijuana Use | 4 | 2020 | 157 | 0.570 |
Why?
| Patient Education as Topic | 5 | 2019 | 699 | 0.540 |
Why?
| Health Services Accessibility | 2 | 2021 | 781 | 0.530 |
Why?
| Policy | 1 | 2016 | 133 | 0.520 |
Why?
| Pneumonia, Viral | 1 | 2020 | 348 | 0.520 |
Why?
| Coronavirus Infections | 1 | 2020 | 339 | 0.520 |
Why?
| Cardiotonic Agents | 1 | 2015 | 127 | 0.510 |
Why?
| Drug Utilization | 1 | 2015 | 169 | 0.500 |
Why?
| Life Change Events | 1 | 2015 | 134 | 0.490 |
Why?
| Patient Readmission | 4 | 2021 | 634 | 0.480 |
Why?
| Patient Care Planning | 3 | 2020 | 143 | 0.470 |
Why?
| Education, Medical | 1 | 2017 | 239 | 0.470 |
Why?
| Decision Making | 4 | 2017 | 809 | 0.470 |
Why?
| Physician's Role | 1 | 2015 | 200 | 0.460 |
Why?
| Patient Discharge | 4 | 2021 | 796 | 0.460 |
Why?
| Nurses | 1 | 2015 | 142 | 0.450 |
Why?
| Quality Assurance, Health Care | 1 | 2015 | 325 | 0.440 |
Why?
| Middle Aged | 14 | 2021 | 27617 | 0.440 |
Why?
| Emergency Service, Hospital | 1 | 2023 | 1865 | 0.420 |
Why?
| Quality of Life | 3 | 2023 | 2366 | 0.420 |
Why?
| Canada | 5 | 2023 | 340 | 0.410 |
Why?
| Depression | 3 | 2018 | 1132 | 0.400 |
Why?
| Culture | 1 | 2012 | 129 | 0.400 |
Why?
| Long-Term Care | 2 | 2021 | 74 | 0.390 |
Why?
| Interpersonal Relations | 1 | 2014 | 345 | 0.390 |
Why?
| Brain Neoplasms | 1 | 2019 | 1022 | 0.390 |
Why?
| Emergency Medical Services | 1 | 2018 | 589 | 0.380 |
Why?
| Health Status | 1 | 2016 | 726 | 0.380 |
Why?
| Health Information Exchange | 2 | 2021 | 12 | 0.380 |
Why?
| Patients | 1 | 2012 | 175 | 0.380 |
Why?
| Melanoma, Experimental | 3 | 2006 | 118 | 0.380 |
Why?
| Resuscitation Orders | 2 | 2021 | 40 | 0.370 |
Why?
| Geriatrics | 2 | 2021 | 68 | 0.370 |
Why?
| Electronic Mail | 2 | 2019 | 55 | 0.340 |
Why?
| Nursing Homes | 2 | 2021 | 130 | 0.340 |
Why?
| Cross-Sectional Studies | 4 | 2023 | 4552 | 0.330 |
Why?
| Influenza, Human | 1 | 2014 | 554 | 0.320 |
Why?
| Peer Group | 2 | 2020 | 207 | 0.320 |
Why?
| Health Communication | 2 | 2019 | 44 | 0.320 |
Why?
| Neuroblastoma | 2 | 2006 | 135 | 0.320 |
Why?
| Hospital Mortality | 1 | 2012 | 814 | 0.310 |
Why?
| Organizations, Nonprofit | 1 | 2007 | 18 | 0.300 |
Why?
| Clinical Decision-Making | 2 | 2022 | 278 | 0.300 |
Why?
| Interviews as Topic | 2 | 2020 | 599 | 0.300 |
Why?
| Retrospective Studies | 5 | 2022 | 12978 | 0.300 |
Why?
| Colorado | 8 | 2023 | 4196 | 0.280 |
Why?
| Health Resources | 1 | 2007 | 132 | 0.270 |
Why?
| Automobile Driving | 2 | 2019 | 128 | 0.270 |
Why?
| Immunotherapy | 2 | 2008 | 493 | 0.270 |
Why?
| Anti-Retroviral Agents | 1 | 2007 | 208 | 0.260 |
Why?
| Adult | 9 | 2021 | 31512 | 0.260 |
Why?
| United States | 8 | 2022 | 12555 | 0.260 |
Why?
| Immunization, Passive | 1 | 2005 | 81 | 0.250 |
Why?
| Antibodies, Bispecific | 1 | 2005 | 33 | 0.250 |
Why?
| Cardiovascular Diseases | 1 | 2016 | 1798 | 0.240 |
Why?
| Healthcare Disparities | 2 | 2021 | 496 | 0.240 |
Why?
| Internet | 2 | 2018 | 633 | 0.240 |
Why?
| T-Lymphocytes | 4 | 2006 | 1774 | 0.240 |
Why?
| Social Work | 2 | 2022 | 69 | 0.230 |
Why?
| Telemedicine | 2 | 2021 | 664 | 0.220 |
Why?
| Referral and Consultation | 2 | 2018 | 648 | 0.220 |
Why?
| Macrophages | 2 | 2006 | 1324 | 0.210 |
Why?
| Interleukin-2 | 3 | 2009 | 416 | 0.210 |
Why?
| Death | 1 | 2022 | 105 | 0.200 |
Why?
| Potentially Inappropriate Medication List | 1 | 2021 | 14 | 0.200 |
Why?
| Macrophages, Peritoneal | 3 | 2006 | 96 | 0.200 |
Why?
| HIV-1 | 1 | 2007 | 776 | 0.200 |
Why?
| Perioperative Care | 1 | 2022 | 132 | 0.200 |
Why?
| Digital Divide | 1 | 2021 | 3 | 0.200 |
Why?
| Deprescriptions | 1 | 2021 | 27 | 0.200 |
Why?
| Tumor Necrosis Factor-alpha | 1 | 2006 | 1171 | 0.190 |
Why?
| Comorbidity | 2 | 2016 | 1527 | 0.190 |
Why?
| Personhood | 1 | 2020 | 4 | 0.190 |
Why?
| Nitric Oxide | 1 | 2006 | 892 | 0.190 |
Why?
| Geriatric Psychiatry | 1 | 2020 | 12 | 0.190 |
Why?
| Receptors, GABA-A | 1 | 2021 | 89 | 0.190 |
Why?
| Pilot Projects | 3 | 2022 | 1419 | 0.190 |
Why?
| Macrophage Activation | 3 | 2006 | 168 | 0.190 |
Why?
| Multiple Chronic Conditions | 1 | 2020 | 24 | 0.190 |
Why?
| Mass Screening | 1 | 2007 | 1052 | 0.180 |
Why?
| Health Expenditures | 1 | 2021 | 174 | 0.180 |
Why?
| Organization and Administration | 1 | 2019 | 9 | 0.180 |
Why?
| Delphi Technique | 2 | 2017 | 164 | 0.180 |
Why?
| Patient Preference | 2 | 2022 | 170 | 0.180 |
Why?
| Europe | 1 | 2020 | 356 | 0.170 |
Why?
| Health Plan Implementation | 1 | 2020 | 133 | 0.170 |
Why?
| Inpatients | 1 | 2023 | 388 | 0.170 |
Why?
| Reimbursement Mechanisms | 1 | 2019 | 79 | 0.170 |
Why?
| Software Design | 1 | 2018 | 23 | 0.170 |
Why?
| Prognosis | 2 | 2018 | 3443 | 0.170 |
Why?
| Medical Futility | 1 | 2018 | 22 | 0.170 |
Why?
| Community-Institutional Relations | 1 | 2019 | 91 | 0.170 |
Why?
| Recreation | 1 | 2018 | 26 | 0.160 |
Why?
| Patient Navigation | 1 | 2020 | 77 | 0.160 |
Why?
| Mentoring | 1 | 2020 | 101 | 0.160 |
Why?
| Practice Guidelines as Topic | 2 | 2017 | 1440 | 0.160 |
Why?
| Developed Countries | 1 | 2018 | 32 | 0.160 |
Why?
| Needs Assessment | 1 | 2020 | 327 | 0.160 |
Why?
| Delivery of Health Care, Integrated | 1 | 2021 | 233 | 0.160 |
Why?
| Rural Population | 1 | 2022 | 452 | 0.160 |
Why?
| Decision Making, Computer-Assisted | 1 | 2018 | 19 | 0.160 |
Why?
| Cytotoxicity, Immunologic | 4 | 2006 | 204 | 0.160 |
Why?
| Neoplasms | 2 | 2022 | 2179 | 0.160 |
Why?
| Prostatic Neoplasms | 1 | 2005 | 940 | 0.150 |
Why?
| Research Personnel | 1 | 2019 | 158 | 0.150 |
Why?
| Longitudinal Studies | 2 | 2016 | 2513 | 0.150 |
Why?
| Video Recording | 1 | 2018 | 156 | 0.150 |
Why?
| Ecosystem | 1 | 2022 | 555 | 0.150 |
Why?
| Reading | 1 | 2018 | 157 | 0.150 |
Why?
| Quality of Health Care | 1 | 2022 | 586 | 0.150 |
Why?
| Program Development | 1 | 2019 | 357 | 0.150 |
Why?
| Academic Medical Centers | 1 | 2019 | 422 | 0.150 |
Why?
| Universities | 1 | 2019 | 347 | 0.140 |
Why?
| Cannabis | 2 | 2020 | 382 | 0.140 |
Why?
| Brain Ischemia | 1 | 2020 | 310 | 0.140 |
Why?
| Health Services Research | 1 | 2019 | 385 | 0.140 |
Why?
| Pain Management | 1 | 2019 | 294 | 0.140 |
Why?
| Community Health Services | 1 | 2018 | 212 | 0.140 |
Why?
| Hypesthesia | 1 | 2016 | 17 | 0.140 |
Why?
| Neoplasms, Experimental | 2 | 2008 | 158 | 0.140 |
Why?
| Young Adult | 3 | 2021 | 10793 | 0.140 |
Why?
| Housing for the Elderly | 1 | 2015 | 7 | 0.140 |
Why?
| Disease Management | 2 | 2019 | 571 | 0.140 |
Why?
| Chest Pain | 1 | 2016 | 84 | 0.130 |
Why?
| Financing, Personal | 1 | 2015 | 27 | 0.130 |
Why?
| Firearms | 1 | 2020 | 281 | 0.130 |
Why?
| Terminology as Topic | 1 | 2017 | 211 | 0.130 |
Why?
| Workflow | 1 | 2016 | 148 | 0.130 |
Why?
| Evidence-Based Medicine | 1 | 2019 | 693 | 0.130 |
Why?
| Professional Role | 1 | 2016 | 153 | 0.130 |
Why?
| Environment | 1 | 2016 | 346 | 0.120 |
Why?
| Curriculum | 1 | 2021 | 910 | 0.120 |
Why?
| Cell Line, Tumor | 6 | 2009 | 2851 | 0.120 |
Why?
| Residence Characteristics | 1 | 2016 | 299 | 0.120 |
Why?
| Family Practice | 1 | 2018 | 438 | 0.120 |
Why?
| Patient Reported Outcome Measures | 1 | 2016 | 252 | 0.120 |
Why?
| Communication Barriers | 1 | 2014 | 94 | 0.120 |
Why?
| Motivational Interviewing | 1 | 2015 | 84 | 0.120 |
Why?
| Cytokines | 4 | 2006 | 1900 | 0.120 |
Why?
| HIV Infections | 1 | 2007 | 2459 | 0.110 |
Why?
| Patient Acceptance of Health Care | 1 | 2018 | 687 | 0.110 |
Why?
| State Medicine | 1 | 2012 | 21 | 0.110 |
Why?
| Pulmonary Disease, Chronic Obstructive | 1 | 2021 | 1137 | 0.110 |
Why?
| Multivariate Analysis | 1 | 2016 | 1474 | 0.100 |
Why?
| Stroke | 1 | 2020 | 1047 | 0.100 |
Why?
| Attitude to Health | 1 | 2015 | 410 | 0.100 |
Why?
| Chronic Disease | 1 | 2017 | 1636 | 0.100 |
Why?
| Severity of Illness Index | 1 | 2018 | 2674 | 0.090 |
Why?
| Respiratory Mechanics | 1 | 1990 | 60 | 0.090 |
Why?
| Goals | 2 | 2022 | 167 | 0.090 |
Why?
| Prevalence | 1 | 2016 | 2326 | 0.090 |
Why?
| Killer Cells, Natural | 3 | 2006 | 381 | 0.080 |
Why?
| Mice, SCID | 2 | 2006 | 333 | 0.080 |
Why?
| Prospective Studies | 2 | 2019 | 6471 | 0.080 |
Why?
| Adolescent | 3 | 2021 | 18480 | 0.080 |
Why?
| Mice, Inbred C57BL | 3 | 2006 | 4908 | 0.080 |
Why?
| Treatment Outcome | 2 | 2020 | 9342 | 0.080 |
Why?
| Recombinant Fusion Proteins | 2 | 2008 | 653 | 0.080 |
Why?
| Feasibility Studies | 2 | 2022 | 749 | 0.080 |
Why?
| Nigeria | 1 | 2007 | 15 | 0.080 |
Why?
| Mice | 8 | 2009 | 15520 | 0.080 |
Why?
| Pulmonary Alveoli | 1 | 1990 | 384 | 0.080 |
Why?
| Immunologic Memory | 1 | 2009 | 313 | 0.080 |
Why?
| Colonic Neoplasms | 1 | 2009 | 224 | 0.070 |
Why?
| Hospitals | 2 | 2022 | 598 | 0.070 |
Why?
| Religion | 1 | 2007 | 68 | 0.070 |
Why?
| NG-Nitroarginine Methyl Ester | 1 | 2006 | 48 | 0.070 |
Why?
| Mice, Inbred A | 1 | 2006 | 45 | 0.070 |
Why?
| Subcutaneous Tissue | 1 | 2006 | 17 | 0.070 |
Why?
| Stress, Psychological | 1 | 2014 | 972 | 0.070 |
Why?
| Toll-Like Receptor 9 | 1 | 2006 | 30 | 0.070 |
Why?
| Vaccination | 1 | 2014 | 1222 | 0.070 |
Why?
| Mice, Mutant Strains | 1 | 2006 | 280 | 0.070 |
Why?
| Neoplasm Transplantation | 1 | 2006 | 245 | 0.070 |
Why?
| Nitric Oxide Synthase | 1 | 2006 | 225 | 0.070 |
Why?
| Self Report | 2 | 2019 | 699 | 0.070 |
Why?
| Veterans | 1 | 2016 | 1208 | 0.060 |
Why?
| Antigen Presentation | 1 | 2006 | 194 | 0.060 |
Why?
| CD3 Complex | 1 | 2005 | 92 | 0.060 |
Why?
| Tumor Cells, Cultured | 1 | 2006 | 874 | 0.060 |
Why?
| Lymphocyte Activation | 2 | 2006 | 1067 | 0.060 |
Why?
| Animals | 10 | 2009 | 33381 | 0.060 |
Why?
| Immunoconjugates | 1 | 2005 | 89 | 0.060 |
Why?
| Risk Factors | 2 | 2019 | 9000 | 0.060 |
Why?
| Terminally Ill | 1 | 2023 | 33 | 0.060 |
Why?
| Morals | 1 | 2023 | 67 | 0.060 |
Why?
| Disclosure | 1 | 2023 | 102 | 0.060 |
Why?
| Adenocarcinoma | 1 | 2009 | 812 | 0.050 |
Why?
| Age Factors | 2 | 2020 | 2995 | 0.050 |
Why?
| Pregnancy Proteins | 1 | 2002 | 38 | 0.050 |
Why?
| Lipopolysaccharides | 1 | 2006 | 870 | 0.050 |
Why?
| Receptor, ErbB-2 | 1 | 2005 | 320 | 0.050 |
Why?
| Enzyme Inhibitors | 1 | 2006 | 827 | 0.050 |
Why?
| Patient Care | 1 | 2023 | 105 | 0.050 |
Why?
| Cohort Studies | 1 | 2012 | 5116 | 0.050 |
Why?
| Interferon-gamma | 1 | 2005 | 736 | 0.050 |
Why?
| Asia | 1 | 2021 | 54 | 0.050 |
Why?
| Benzodiazepines | 1 | 2021 | 122 | 0.050 |
Why?
| Neutrophils | 1 | 2006 | 1233 | 0.050 |
Why?
| Ownership | 1 | 2020 | 79 | 0.050 |
Why?
| Thrombectomy | 1 | 2020 | 60 | 0.040 |
Why?
| Senior Centers | 1 | 2019 | 1 | 0.040 |
Why?
| Factor Analysis, Statistical | 1 | 2020 | 270 | 0.040 |
Why?
| Mortality | 1 | 2021 | 299 | 0.040 |
Why?
| Interprofessional Relations | 1 | 2021 | 261 | 0.040 |
Why?
| Confidentiality | 1 | 2019 | 67 | 0.040 |
Why?
| Vulnerable Populations | 1 | 2020 | 147 | 0.040 |
Why?
| Safety | 1 | 2020 | 304 | 0.040 |
Why?
| Informed Consent | 1 | 2019 | 163 | 0.040 |
Why?
| Minority Health | 1 | 2018 | 20 | 0.040 |
Why?
| Professional-Patient Relations | 1 | 2019 | 147 | 0.040 |
Why?
| Social Values | 1 | 2018 | 38 | 0.040 |
Why?
| Rats | 1 | 2006 | 5392 | 0.040 |
Why?
| Interdisciplinary Research | 1 | 2017 | 27 | 0.040 |
Why?
| California | 1 | 2018 | 382 | 0.040 |
Why?
| Students | 1 | 2021 | 509 | 0.040 |
Why?
| Internationality | 1 | 2017 | 152 | 0.030 |
Why?
| Patient Safety | 1 | 2019 | 281 | 0.030 |
Why?
| Racism | 1 | 2018 | 102 | 0.030 |
Why?
| Socioeconomic Factors | 1 | 2020 | 1129 | 0.030 |
Why?
| Time Factors | 3 | 2020 | 6412 | 0.030 |
Why?
| Personal Autonomy | 1 | 2015 | 41 | 0.030 |
Why?
| Flow Cytometry | 2 | 2008 | 1085 | 0.030 |
Why?
| Delivery of Health Care | 1 | 2020 | 867 | 0.030 |
Why?
| Empathy | 1 | 2015 | 142 | 0.030 |
Why?
| Pain | 1 | 2018 | 735 | 0.030 |
Why?
| Reproducibility of Results | 1 | 2020 | 2874 | 0.030 |
Why?
| Anxiety | 1 | 2018 | 845 | 0.030 |
Why?
| Spleen | 2 | 2004 | 510 | 0.030 |
Why?
| Lung Volume Measurements | 1 | 1990 | 46 | 0.020 |
Why?
| Gerbillinae | 1 | 1990 | 63 | 0.020 |
Why?
| Pressure | 1 | 1990 | 226 | 0.020 |
Why?
| Cell Membrane Permeability | 1 | 1989 | 88 | 0.020 |
Why?
| Albumins | 1 | 1989 | 100 | 0.020 |
Why?
| Thrombin | 1 | 1989 | 143 | 0.020 |
Why?
| Child | 1 | 2007 | 19129 | 0.020 |
Why?
| Peptides, Cyclic | 1 | 1989 | 260 | 0.020 |
Why?
| Mice, Inbred BALB C | 1 | 2009 | 1206 | 0.020 |
Why?
| Combined Modality Therapy | 1 | 2009 | 1166 | 0.020 |
Why?
| Catheter Ablation | 1 | 2009 | 286 | 0.020 |
Why?
| Apoptosis | 2 | 2006 | 2484 | 0.020 |
Why?
| Leukemia L5178 | 1 | 2005 | 1 | 0.020 |
Why?
| CpG Islands | 1 | 2006 | 119 | 0.020 |
Why?
| Cell Division | 2 | 2002 | 776 | 0.020 |
Why?
| Xenograft Model Antitumor Assays | 1 | 2008 | 740 | 0.020 |
Why?
| Jurkat Cells | 1 | 2005 | 134 | 0.020 |
Why?
| Immunophenotyping | 1 | 2006 | 278 | 0.020 |
Why?
| Mice, Inbred C3H | 1 | 2005 | 250 | 0.020 |
Why?
| Coculture Techniques | 1 | 2005 | 208 | 0.020 |
Why?
| Liver Neoplasms, Experimental | 1 | 2004 | 25 | 0.020 |
Why?
| Gangliosides | 1 | 2004 | 19 | 0.020 |
Why?
| Cytoplasm | 1 | 2005 | 269 | 0.020 |
Why?
| Mice, Inbred Strains | 1 | 2004 | 405 | 0.010 |
Why?
| Ligands | 1 | 2005 | 567 | 0.010 |
Why?
| Megakaryocytes | 1 | 2002 | 30 | 0.010 |
Why?
| Endothelium, Vascular | 1 | 1989 | 907 | 0.010 |
Why?
| CHO Cells | 1 | 2002 | 143 | 0.010 |
Why?
| Cricetinae | 1 | 2002 | 262 | 0.010 |
Why?
| Neoplasm Metastasis | 1 | 2004 | 544 | 0.010 |
Why?
| Bone Marrow Cells | 1 | 2002 | 273 | 0.010 |
Why?
| Gestational Age | 1 | 2002 | 765 | 0.010 |
Why?
| Hematopoietic Stem Cells | 1 | 2002 | 359 | 0.010 |
Why?
| Recombinant Proteins | 1 | 2002 | 1308 | 0.010 |
Why?
| Mice, Knockout | 1 | 2005 | 2680 | 0.010 |
Why?
| Fetus | 1 | 2002 | 690 | 0.010 |
Why?
| Cell Differentiation | 1 | 2002 | 1753 | 0.010 |
Why?
| Cells, Cultured | 1 | 2002 | 4077 | 0.010 |
Why?
| Pregnancy | 1 | 2002 | 5691 | 0.010 |
Why?
| Microscopy, Fluorescence | 1 | 1989 | 412 | 0.000 |
Why?
| Actins | 1 | 1989 | 404 | 0.000 |
Why?
| Cattle | 1 | 1989 | 978 | 0.000 |
Why?
| Cell Survival | 1 | 1989 | 1047 | 0.000 |
Why?
| Cell Membrane | 1 | 1989 | 710 | 0.000 |
Why?
|
|
Lum's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|